Search

Concluding its final phase of the Small Business Pulse Survey (SBPS), the U.S. Census Bureau released findings comparing responses from early in the pandemic to those collected the first week in January. From early responses collected in April 2020 to those collected this winter, business expectations of a return to normal level of operations have shifted so that there are many businesses with expectations at opposite extremes: businesses with expectation of a short-term return to normal and those facing long-term challenges.

A large majority (nearly 87 percent) of U.S. counties showed growth in their gross domestic product (GDP) from 2018 to 2019, according to an SSTI analysis of data from the U.S. Bureau of Economic Analysis (BEA). GDP is the measure for the total value of goods and services produced in an area, and is one of the primary economic indicators used by researchers and policymakers. This edition of Useful Stats examines the recently updated (BEA) data and provides an analysis of 2019 total county GDP, 2019 county GDP per capita, and the percent change in each measure from 2018 to 2019.

A recent study exploring the science underlying all 356 pharmaceutical drugs approved by the Center for Drug Evaluation and Research since 2010, found each drug is based on life science investments the public sector has made through the National Institutes of Health (NIH).

In the wake of the Great Recession, Congress enacted the Budget Control Act (BCA) of 2011 to curb federal discretionary spending as the nation approached the statutory debt limit. Originally intended to reduce spending by nearly $2 trillion over the period from FY 2012 through FY 2021, the BCA spending caps were periodically raised by Congress.

Last week, the incoming Biden administration announced an “American Rescue Plan” to address immediate health and economic threats from COVID-19. On the economic side, the plan goes further than immediate relief and begins to address some longer-term strength and resilience concerns. Among other provisions, it would provide $35 billion for a new business finance program that support venture capital, $350 billion for state and local governments to help address budget shortfalls, $35 billion for higher education and $3 billion for the Economic Development Administration.

The U.S. Small Business Administration has announced the winners of two award programs. The Lab to Market (L2M) competition was launched in September and recognizes organizations, programs and ideas that support R&D innovation ecosytems, particularly those focused on underrepresented communities and pandemic responses. SBA also announced recipients of the annual Tibbetts Awards, which recognizes companies, organizations, and individuals for exceptional success achieved through the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs.

The Economic Development Administration (EDA) has announced the seven recipients of the inaugural STEM Talent Challenge, awarding a total of $2 million in grants through the inaugural STEM Talent Challenge, which aims to boost local science, technology, engineering, and math (STEM) talent.

President Joe Biden’s nominees to economic and energy roles have experience with regional growth initiatives. Readers of the Digest may be familiar with some of the names, as we have covered their activities in their previous roles. The nominees of the president’s economic team include former Rhode Island Gov. Gina Raimondo, nominated to lead the U.S. Department of Commerce, and Don Graves as deputy secretary; Isabel Guzman nominated to become administrator of the Small Business Administration (SBA); former Michigan Gov.

President Joe Biden has named geneticist Eric Lander the director of the Office of Science and Technology Policy (OSTP) and the president’s science advisor. Biden also promoted the science advisor role to a cabinet-level position, becoming the first president to do so, stating that, “science will always be at the forefront of my administration.”

Deals raising at least $50 million grew by nearly one-quarter in 2020, driving an additional $18 billion in deal value to a new record of $156 billion invested. This data, from the PitchBook-NVCA Venture Monitor, suggests that the total venture capital market will see a slight decline in investment deals overall from 2020.[1] This slip in deal activity is driven by what is currently an 11 percent decline in seed or angel deals and a 20 percent decline in early venture capital deals.

Nearly 75 years ago, the head of the U.S. Office of Scientific Research and Development, Vannevar Bush, published what became a seminal report in the science community. The report chronicled the necessity of basic scientific research, investment by government in science and innovation, and identified the reasons to push the limits of our own knowledge. Science, The Endless Frontier was Bush’s call for a committed relationship between government and science.

Each year more than half of the discretionary portion of the federal budget is spent by the Department of Defense (DOD). In FY 2019, the DOD figure is estimated to be $712.5 billion and 77 percent of it was spent in the 50 states and District of Columbus, based on a new report from the Office of Local Defense Community Cooperation (OLDCC) — formerly the Office of Economic Adjustment. The report outlines those DoD personnel and contractual expenditures in each state for the year.

The U.S. Department of Energy announced more than $123 million across 46 awards to projects supporting manufacturing innovation. About half of the funds are going to efficiency improvements in manufacturing processes, with the remainder split between improving chemical manufacturing and supporting more efficient facilities and systems. SSTI members included among the project awardees include Argonne National Lab, Sandia National Lab, University of Cincinnati, University of Michigan, and the University of Tennessee.

Beginning in early March, potential wage levels will play a leading role in the selection process that determines H-1B visa recipients, worrying some that it may result in a decrease in the number of international students wanting to pursue their education in the U.S.

The early days of vaccinating against the coronavirus might not be the most receptive time to raise issues of antitrust in the U.S. pharmaceutical industry, but a November 2020 Barcelona GSW Working Paper raises several concerns about the degree and effect of common ownership within big pharma. Does this explain the resistance of drug prices to fall? Should Congress take on the likes of brand firms Johnson & Johnson, Merck and Pfizer, in addition to already challenging the tech giants, in 2021?

Entrepreneurship in the U.S. has declined significantly over the past four decades, which has contributed to an annual productivity growth of 3 to 4 percent less than it would be if entrepreneurship had remained unchanged since the early 1980s. Those are among the findings a report from the Congressional Budget Office (CBO), which points to three contributing factors for the decline and outlines measures policymakers could put in place to help spur entrepreneurship.

As 2020 came to a close, we received word that former Pennsylvania Gov. Dick Thornburgh had passed away on Dec. 31.

This week’s SSTI Weekly Digest contains a full slate of stories, some of which focus on the federal government. To report these stories without commenting on yesterday’s events and not acknowledge what has occurred over the last 24 hours could give the impression that we do not think the assault on the Capitol was significant. Nothing could be further from the truth. 

Before America had a pandemic to fight, U.S. governors collectively expected 10.8 percent more revenue to work with in FY 2021 than current estimates projected in the latest National Association of State Budget Officers (NASBO) survey. Thirty-five states reported in the semi-annual survey released Dec. 23 that general funds had not met expectations for FY 2020; 19 states made mid-year cuts as a result.

The United States Patent and Trademark Office (USPTO) has issued a request for comments regarding the development of a national strategy to build a more demographically, geographically and economically inclusive innovation ecosystem.

A thriving innovation economy requires a robust R&D enterprise — with participation by academia, government, and the private sector. As a substantial performer and funder of R&D in the United States, the strength of private industry’s R&D activity in a region can provide an indication of the region’s capacity for bringing innovative technologies to market.

The National Institute of Standards and Technology (NIST) has continued to follow through on improvements to federal technology transfer proposed through the Return on Investment initiative. In December, the agency revealed legislative text for statutory changes and, on Monday, released a notice of proposed rulemaking related to Bayh-Dole.

Near the end of 2020, Congress passed the FY 2021 defense authorization (overriding a presidential veto) and folded multiple policy bills into the joint appropriations and coronavirus relief bill. This legislation includes new authorizations for semiconductor research facilities, clean and renewable energy innovation, and new studies of assets for critical research areas.

Innovation-related policies within the National Defense Authorization Act (NDAA) for FY 2021 include the following:

The final FY 2021 budget provides $1.4 trillion in total federal funding, including increases in some programs affecting the innovation economy. Among SSTI’s Innovation Advocacy Council priorities: EDA’s Build to Scale received an appropriation of $38 million, SBA’s Regional Innovation Clusters received $6 million, and SBA’s Federal and State Technology (FAST) program received $4 million. These are just a few of the federally-funded initiatives that support regional innovation economies and a wide range of federal R&D activities.

The relief bill passed last night falls short of assisting states that face strains on their budgets and increasing demand for assistance from their constituents. However, the bill does provide $900 billion for the first broad COVID-19 relief package to pass since the CARES Act was signed into law on March 27th. The major items in this legislation are the extension of unemployment insurance benefits, direct payments to individuals, and a new round of loans through a modified Paycheck Protection Program.